Vijayam Bio Cytes Profile
Key Indicators
- Authorised Capital ₹ 3.50 Cr
as on 03-07-2024
- Paid Up Capital ₹ 3.50 Cr
as on 03-07-2024
- Company Age 21 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.00 Cr
as on 03-07-2024
- Satisfied Charges ₹ 9.30 M
as on 03-07-2024
- Revenue 10647.39%
(FY 2023)
- Profit 89.01%
(FY 2023)
- Ebitda 295.92%
(FY 2023)
- Net Worth -0.38%
(FY 2023)
- Total Assets 15.83%
(FY 2023)
About Vijayam Bio Cytes
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 Cr and a paid-up capital of Rs 3.50 Cr.
The company currently has active open charges totaling ₹12.00 Cr. The company has closed loans amounting to ₹9.30 M, as per Ministry of Corporate Affairs (MCA) records.
Vijayakumar Madupalli, Padmini Nagarajan, Kailasam Nagarajan, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24299TN2003PTC051854
- Company No.
051854
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Oct 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Vijayam Bio Cytes?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mohanagupta Madupalli | Managing Director | 20-Jan-2016 | Current |
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vijayakumar Madupalli | Director | 17-Jul-2020 | Current |
Padmini Nagarajan | Director | 30-Oct-2003 | Current |
Kailasam Nagarajan | Director | 30-Oct-2003 | Current |
Krishnakishore Madupalli | Director | 30-Mar-2016 | Current |
Financial Performance and Corporate Structure Insights of Vijayam Bio Cytes.
Vijayam Bio Cytes Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10647.39% increase. The company also saw a substantial improvement in profitability, with a 89.01% increase in profit. The company's net worth dipped by a decrease of 0.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Vijayam Bio Cytes?
In 2023, Vijayam Bio Cytes had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Young Presidents Organisation (Chennai Chapter)Active 25 years 9 months
Vijayakumar Madupalli is a mutual person
- Gupta Hair Products Private LimitedActive 23 years 1 month
Vijayakumar Madupalli, Mohanagupta Madupalli and 1 more are mutual person
- M.M.G. Assets LlpActive 4 years 9 months
Vijayakumar Madupalli, Mohanagupta Madupalli and 1 more are mutual person
- M.M.G.Holdings Private LimitedActive 20 years 8 months
Vijayakumar Madupalli, Mohanagupta Madupalli and 1 more are mutual person
- M.M.G. Ventures Private LimitedActive 5 years 7 months
Vijayakumar Madupalli, Mohanagupta Madupalli and 1 more are mutual person
- Vijayalakshmi Theatres Private LimitedActive 12 years 7 months
Vijayakumar Madupalli and Mohanagupta Madupalli are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 22 Feb 2021 | ₹12.00 Cr | Open |
Catholic Syrian Bank Creation Date: 02 May 2011 | ₹2.25 M | Satisfied |
Catholic Syrian Bank Creation Date: 02 May 2011 | ₹2.25 M | Satisfied |
How Many Employees Work at Vijayam Bio Cytes?
Unlock and access historical data on people associated with Vijayam Bio Cytes, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vijayam Bio Cytes, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vijayam Bio Cytes's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.